Cancer research is moving faster than most people realize.
Russia just announced Enteromix, a personalized mRNA cancer vaccine showing promising early results in colorectal cancer patients. Tumor reduction of 60-80% in Phase I trials. The world is paying attention and they should be.
The concept of turning a patient's own tumor into a personalized vaccine has been explored for quite some time. The approach involves ablating the tumor, then injecting combinations of immunotherapy agents directly into it. Checkpoint inhibitors, TLR agonists, vaccine adjuvants. The dead tumor cells become antigens and the immune system learns what to hunt. Not one target. Dozens. All unique to that patient's cancer.
Off-the-shelf vaccines typically target a single antigen. But cancer is smart. It mutates. It hides. A single target is like having one photo of a suspect. When you use the patient's own tumor as the vaccine, you give the immune system the photo, the fingerprints, the DNA, the scars, the tattoos. Good luck hiding from that.
The entire field is moving toward a truth the science has pointed to for a long time: the cure for cancer is already within you. Your immune system just needs to be taught what to fight and where to fight it.
We are living in the most exciting era of cancer treatment in human history. This is the immunotherapy revolution and it's accelerating.
If you or someone you love is fighting cancer, know this. There are more options today than at any point in history.
🚨: Russia has announced that its new cancer vaccine, Enteromix, has shown 100% success in clinical trials and is now ready for clinical use.